Datasheet is currently unavailable. Try again or CONTACT US
rHuman RELM beta Protein
009-001-W18-1000
1 mg
Lyophilized
SDS-PAGE
Human
E. coli
This product is discontinued
Product Details
Human RELM beta Recombinant Protein - 009-001-W18-1000
FIZZ2
Human
E. coli
Recombinant Protein
Target Details
RELM-beta - View All RELM-beta Products
RELM beta purity was determined to be greater than 90% as determined by analysis by UV-Spectroscopy at 280nm.
Q2UXL7 - UniProtKB
Application Details
SDS-PAGE
RELM beta Recombinant Protein has been tested by SDDS-PAGE and is suitable as a control for polyclonal or monoclonal anti-RELM beta in immunological assays.
Formulation
0.1% Trifluoroacetic acid
None
None
1.0 mL
Restore with deionized water (or equivalent)
Shipping & Handling
Ambient
Store vial at 4° C prior to restoration. Dilute only prior to immediate use. Maintain sterility. This product DOES NOT contain preservative. DO NOT VORTEX. We recommend adding a carrier protein such as HSA or BSA to 0.1% (i.e. 1.0 mg/mL). For best results aliquot contents and freeze at -20° C or colder. Avoid cycles of freezing and thawing. Centrifuge vial before each opening to dislodge contents from the cap and to clarify if contents are not clear after standing at room temperature.
Expiration date is six (6) months from date of receipt.
Resistin-Like Molecule-beta (RELM- β) is a member of a recently identified family of secreted proteins containing conserved cysteines in their C terminus. The RELM family consists of Resistin (also called FIZZ3), RELM-α (FIZZ1), and RELM-γ. Only Resistin and RELM-β were found in humans whereas all four RELM family members have been identified in rodents. Recombinant human RELM-β is a non-glycosylated, disulfide-linked homodimer, containing two 89 amino acid chains, with a total molecular weight of 19 kDa.
This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.